Willemijn D Scholten1, Neeltje M Batelaan2, Brenda W J H Penninx3, Anton J L M van Balkom2, Johannes H Smit4, Robert A Schoevers5, Patricia van Oppen2. 1. Department of Psychiatry, VU University Medical Center, A.J. Ernststraat 1187, 1081 HL Amsterdam, The Netherlands; EMGO Institute for Health and Care Research, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. Electronic address: w.scholten@ggzingeest.nl. 2. Department of Psychiatry, VU University Medical Center, A.J. Ernststraat 1187, 1081 HL Amsterdam, The Netherlands; EMGO Institute for Health and Care Research, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. 3. Department of Psychiatry, VU University Medical Center, A.J. Ernststraat 1187, 1081 HL Amsterdam, The Netherlands; EMGO Institute for Health and Care Research, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands; Neuroscience Campus Amsterdam, VU University Medical Center, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands; Department of Psychiatry, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands; Department of Psychiatry, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The Netherlands. 4. Department of Psychiatry, VU University Medical Center, A.J. Ernststraat 1187, 1081 HL Amsterdam, The Netherlands; EMGO Institute for Health and Care Research, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands; Neuroscience Campus Amsterdam, VU University Medical Center, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands. 5. Department of Psychiatry, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands.
Abstract
BACKGROUND: Despite increasing evidence for the diagnostic instability between and within depressive and anxiety disorders, most studies report solely on the recurrence rates of the specific index disorders. Neglecting this evidence has an inherent risk of underestimating recurrence rates of depressive and anxiety disorders. This study investigates the impact of diagnostic instability of recurrence rates in depression and anxiety. METHODS: Data were derived from the Netherlands Study of Depression and Anxiety (NESDA). The sample of 656 participants had a panic disorder with or without agoraphobia, agoraphobia, social phobia, generalized anxiety disorder, major depressive disorder or dysthymia, and a subsequent remission. Recurrence rates of index disorders (diagnostically stable recurrence) and newly arisen anxiety or depressive disorders (diagnostically unstable recurrence), were calculated over a 4-year follow-up period. RESULTS: In anxiety disorders (n=281), the recurrence rate is more than doubled, from 23.8% with a stable recurrence, to 54.8%, when diagnostically unstable recurrences are included. In depressive disorders (N=173) the recurrence rate increases from 37.6% to 49.7%, and in comorbid anxiety and depressive disorders (N=202) the diagnostically unstable recurrences increase from 54.0% to 66.3%. LIMITATIONS: Attrition during follow up may have biased the results; remission was defined as absence of symptoms for 1 month; very short-term remission and recurrence patterns were not assessed. CONCLUSIONS: Diagnostically unstable recurrences have a significant impact on recurrence rates, with the greatest instability for anxiety disorders. When only diagnostically stable recurrences are assessed, recurrence rates are highly underrated and provide biased estimates of the true course of these disorders.
BACKGROUND: Despite increasing evidence for the diagnostic instability between and within depressive and anxiety disorders, most studies report solely on the recurrence rates of the specific index disorders. Neglecting this evidence has an inherent risk of underestimating recurrence rates of depressive and anxiety disorders. This study investigates the impact of diagnostic instability of recurrence rates in depression and anxiety. METHODS: Data were derived from the Netherlands Study of Depression and Anxiety (NESDA). The sample of 656 participants had a panic disorder with or without agoraphobia, agoraphobia, social phobia, generalized anxiety disorder, major depressive disorder or dysthymia, and a subsequent remission. Recurrence rates of index disorders (diagnostically stable recurrence) and newly arisen anxiety or depressive disorders (diagnostically unstable recurrence), were calculated over a 4-year follow-up period. RESULTS: In anxiety disorders (n=281), the recurrence rate is more than doubled, from 23.8% with a stable recurrence, to 54.8%, when diagnostically unstable recurrences are included. In depressive disorders (N=173) the recurrence rate increases from 37.6% to 49.7%, and in comorbid anxiety and depressive disorders (N=202) the diagnostically unstable recurrences increase from 54.0% to 66.3%. LIMITATIONS: Attrition during follow up may have biased the results; remission was defined as absence of symptoms for 1 month; very short-term remission and recurrence patterns were not assessed. CONCLUSIONS: Diagnostically unstable recurrences have a significant impact on recurrence rates, with the greatest instability for anxiety disorders. When only diagnostically stable recurrences are assessed, recurrence rates are highly underrated and provide biased estimates of the true course of these disorders.
Authors: Juyoen Hur; Kathryn A DeYoung; Samiha Islam; Allegra S Anderson; Matthew G Barstead; Alexander J Shackman Journal: Psychol Med Date: 2019-08-19 Impact factor: 7.723
Authors: Mieke Klein Hofmeijer-Sevink; Neeltje M Batelaan; Harold J G M van Megen; Marcel A van den Hout; Brenda W Penninx; Anton J L M van Balkom; Danielle C Cath Journal: Can J Psychiatry Date: 2017-05-16 Impact factor: 4.356
Authors: Bradley S Peterson; Amy E West; John R Weisz; Wendy J Mack; Michele D Kipke; Robert L Findling; Brian S Mittman; Ravi Bansal; Steven Piantadosi; Glenn Takata; Corinna Koebnick; Ceth Ashen; Christopher Snowdy; Marie Poulsen; Bhavana Kumar Arora; Courtney M Allem; Marisa Perez; Stephanie N Marcy; Bradley O Hudson; Stephanie H Chan; Robin Weersing Journal: BMC Psychiatry Date: 2021-06-30 Impact factor: 3.630
Authors: Sascha Y Struijs; Femke Lamers; Mike Rinck; Karin Roelofs; Philip Spinhoven; Brenda W J H Penninx Journal: Depress Anxiety Date: 2018-04-24 Impact factor: 6.505
Authors: Neeltje M Batelaan; Renske C Bosman; Anna Muntingh; Willemijn D Scholten; Klaas M Huijbregts; Anton J L M van Balkom Journal: BMJ Date: 2017-09-13